Harmony Biosciences II, Inc. — Form D

Harmony Biosciences II, Inc. of PLYMOUTH MEETING, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-22. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Jeffrey AroninDirectorExton, PA
MARTIN BECH EDWARDSDirectorPLYMOUTH MEETING, PA
WILBUR BECH GANTZ, IIIDirectorPLYMOUTH MEETING, PA
ANTONIO GRACIASDirectorHawthorne, CA
JOHN JACOBSDirectorAUBURN, WA
JACK BECH NIELSENDirectorPLYMOUTH MEETING, PA
AARON BECH ROYSTONDirectorPLYMOUTH MEETING, PA
Juan SabaterDirectorCHICAGO, IL
DR. ANDREAS BECH WICKIDirectorPLYMOUTH MEETING, PA
JOHN JACOBSExecutive OfficerAUBURN, WA
Patrick MorrisExecutive OfficerChicago, IL
ANDREW SERAFINExecutive OfficerPLYMOUTH MEETING, PA
JOHN VITTORIAExecutive OfficerPLYMOUTH MEETING, PA
OCTAGON BECH CAPITAL GROUP, LLCPromoterMILLBURN, NJ
Darien ParhadExecutive OfficerExton, PA
Aaron RoystonDirectorCambridge, MA
Jack NielsenDirectorPalo Alto, CA
Martin EdwardsDirectorBoston, MA
Dr. Andreas WickiDirectorNorthbrook, IL
Robert RepellaDirectorNorthbrook, IL
Robert RepellaExecutive OfficerNorthbrook, IL
Wilbur Gantz IIIDirectorNorthbrook, IL
Wilbur Bech Gantz IIIDirectorNorthbrook, IL

Other filings by this issuer (2)

FiledFormOfferingSold
2018-01-18D$25.0M$25.0M
2017-10-06D$270.0M$270.0M

More